# Randomized Trial of ARCON in Larynx Cancer

> **NCT00147732** · PHASE3 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 345 (actual)

## Conditions studied

- Larynx Carcinoma

## Interventions

- **RADIATION:** Accelerated radiotherapy
- **RADIATION:** ARCON

## Key facts

- **NCT ID:** NCT00147732
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2008-02
- **Final completion:** 2013-04
- **Target enrollment:** 345 (ACTUAL)
- **Last updated:** 2015-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00147732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00147732, "Randomized Trial of ARCON in Larynx Cancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00147732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*